Recently, several reports have demonstrated that A3B was upregulated in different tumours, such as breast cancer [18] and HBV-associated HCC [17], and this upregulation was correlated with genomic C to T mutations [18], implicating A3B is involved in in cancer mutagenesis and development [23]. Here, APOBEC3B is linked to breast cancer.